Summary by Moomoo AI
On 20 March 2024, Dongsun Changjiang Pharmaceutical (stock code: 01558.HK) disclosed a privatization transaction pursuant to Rule 22 of the Hong Kong Code of Companies on Acquisitions and Mergers. The transaction was executed by CICC Financial Trading Limited on 19 March 2024 and involved the purchase and sale of 102,800 shares of common stock. The total amount of shares purchased was $1,078,524.65, with a maximum price of $10.4915 per share; the total amount of shares sold was $1,081,417.30, with a maximum price of $10.5196 per share. The transaction is a proprietary transaction and is completed before the end of the morning trading session on the trading day after the initial transaction. CICC Financial Trading Limited is an exempt self-dealing seller associated with the Contracting Party and this transaction is conducted on its own account.